Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy : JANUS 1 and 2 randomized phase III studies

Simple item page
dc.contributor.authorHurwitz, Herbert
dc.contributor.authorVan Cutsem, Eric
dc.contributor.authorBendell, Johanna
dc.contributor.authorHidalgo, Manuel
dc.contributor.authorChung-Pin Li
dc.contributor.authorGarrido S., Marcelo
dc.contributor.authorMacarulla, Teresa
dc.contributor.authorSahai, Vaibhav
dc.contributor.authorSama, Ashwin
dc.contributor.authorGreeno, Edward
dc.date.accessioned2020-11-25T17:28:43Z
dc.date.available2020-11-25T17:28:43Z
dc.date.issued2018
dc.format.extent13 páginas
dc.fuente.origenConveris
dc.identifier.doi10.1007/s10637-018-0580-2
dc.identifier.issn0167-6997
dc.identifier.issn1573-0646
dc.identifier.urihttps://doi.org/10.1007/s10637-018-0580-2
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/48463
dc.issue.numeroNo. 4
dc.language.isoen
dc.nota.accesoContenido parcial
dc.pagina.final695
dc.pagina.inicio683
dc.revistaInvestigational New Drugses_ES
dc.rightsacceso restringido
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherCáncer de páncreas - Terapiaes_ES
dc.subject.otherNeoplasias pancreáticases_ES
dc.subject.otherQuimioterapiaes_ES
dc.titleRuxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy : JANUS 1 and 2 randomized phase III studieses_ES
dc.typeartículo
dc.volumenVol. 36
sipa.codpersvinculados7260
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Ruxolitinib + capecitabine in advanced-metastatic pancreatic cancer after disease progression-intolerance to first-line therapy JANUS 1 and 2 randomized phase III studies.pdf
Size:
3.28 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas